MedTrace Logo

Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma

NCT01709253 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2017-03-29

No results posted yet for this study

Summary

Phase 2 hypofractionation study usion proton beam therapy for prostate adenocarcinoma

Conditions

  • Prostate Adenocarcinoma

Interventions

RADIATION

proton beam therapy

hypofractionation study using proton beam therapy for prostate adenocarcinoma

Sponsors & Collaborators

  • National Cancer Center, Korea

    lead OTHER_GOV

Principal Investigators

  • kwan ho cho, M.D. · National Cancer Center, Korea

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01709253 on ClinicalTrials.gov